Andy Chen Score: 38
Analyst at
Wolfe Research
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+49.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
60%
9 W / 6 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
77%
10 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
56%
5 W / 4 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
58%
7 W / 5 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
67%
2 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$78.00
Est. +39%
|
$56.28 | $58.77 |
Pending
|
$48.71
-13.5%
|
| Aug 10, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$562.00
Est. +8%
|
$522.78 | $560.25 |
Bullseye Hit (±1%)
|
$508.75
-2.7%
|
| Jul 15, 2026 |
Intellia Therapeutics Inc
NTLA
|
SELL |
$9.00
Est. +31%
|
$13.04 | $10.15 (Low) |
Pending
|
$11.34
+13.0%
|
| Apr 08, 2026 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$98.00
Est. +12%
|
$87.48 | $116.45 |
Target Met
|
$74.53
-14.8%
|
| Jan 06, 2026 |
Madrigal Pharmaceuticals Inc
MDGL
|
SELL |
$579.00
Est. +2%
|
$588.40 | $418.72 (Low) |
Target Met
|
$459.81
+21.9%
|
| Dec 18, 2025 |
Insmed Inc
INSM
|
SELL |
$167.00
Est. +16%
|
$198.46 | $90.39 (Low) |
Target Met
|
$99.21
+50.0%
|
| Feb 04, 2025 |
AnaptysBio Inc
ANAB
|
BUY |
$25.00
Est. +50%
|
$16.66 | $34.98 |
Target Met
|
$48.71
+192.4%
|
| Feb 04, 2025 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$20.00
Est. +46%
|
$13.70 | $36.51 |
Target Met
|
$73.87
+439.2%
|
| Sep 30, 2024 |
Incyte Corp.
INCY
|
BUY |
$84.00
Est. +27%
|
$66.10 | $87.99 |
Target Met
|
$113.27
+71.4%
|
| Aug 26, 2024 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$65.00
Est. +36%
|
$47.78 | $53.27 |
Miss
|
$108.14
+126.3%
|
| Aug 05, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$576.00
Est. +21%
|
$476.91 | $519.88 |
Miss
|
$508.75
+6.7%
|
| Jun 10, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$29.00
Est. +375%
|
$6.11 | $27.20 |
Miss
|
$19.56
+220.1%
|
| Jun 10, 2024 |
Akero Therapeutics Inc
AKRO
|
BUY |
$40.00
Est. +74%
|
$22.99 | $58.40 |
Target Met
|
$54.65
+137.7%
|
| May 29, 2024 |
Insmed Inc
INSM
|
BUY |
$54.00
Est. +12%
|
$48.06 | $84.87 |
Target Met
|
$99.21
+106.4%
|
| Mar 20, 2024 |
Alpine Immune Sciences Inc
ALPN
|
BUY |
$46.00
Est. +14%
|
$40.23 | $65.00 |
Target Met
|
$64.97
+61.5%
|
AnaptysBio Inc
ANAB
Aug 31, 2026
Signal & Target
BUY
$78.00
Start Price
$56.28
Best Price (1Y)
$58.77
Current Price
$48.71
Return
-13.5%
Vertex Pharmaceuticals, Inc.
VRTX
Aug 10, 2026
Signal & Target
BUY
$562.00
Start Price
$522.78
Best Price (1Y)
$560.25
Current Price
$508.75
Return
-2.7%
Intellia Therapeutics Inc
NTLA
Jul 15, 2026
Signal & Target
SELL
$9.00
Start Price
$13.04
Best Price (1Y)
$10.15
Current Price
$11.34
Return
+13.0%
Dianthus Therapeutics Inc
DNTH
Apr 08, 2026
Signal & Target
BUY
$98.00
Start Price
$87.48
Best Price (1Y)
$116.45
Current Price
$74.53
Return
-14.8%
Madrigal Pharmaceuticals Inc
MDGL
Jan 06, 2026
Signal & Target
SELL
$579.00
Start Price
$588.40
Best Price (1Y)
$418.72
Current Price
$459.81
Return
+21.9%
Insmed Inc
INSM
Dec 18, 2025
Signal & Target
SELL
$167.00
Start Price
$198.46
Best Price (1Y)
$90.39
Current Price
$99.21
Return
+50.0%
AnaptysBio Inc
ANAB
Feb 04, 2025
Signal & Target
BUY
$25.00
Start Price
$16.66
Best Price (1Y)
$34.98
Current Price
$48.71
Return
+192.4%
Oruka Therapeutics, Inc.
ORKA
Feb 04, 2025
Signal & Target
BUY
$20.00
Start Price
$13.70
Best Price (1Y)
$36.51
Current Price
$73.87
Return
+439.2%
Incyte Corp.
INCY
Sep 30, 2024
Signal & Target
BUY
$84.00
Start Price
$66.10
Best Price (1Y)
$87.99
Current Price
$113.27
Return
+71.4%
Kymera Therapeutics Inc
KYMR
Aug 26, 2024
Signal & Target
BUY
$65.00
Start Price
$47.78
Best Price (1Y)
$53.27
Current Price
$108.14
Return
+126.3%
Vertex Pharmaceuticals, Inc.
VRTX
Aug 05, 2024
Signal & Target
BUY
$576.00
Start Price
$476.91
Best Price (1Y)
$519.88
Current Price
$508.75
Return
+6.7%
Viridian Therapeutics Inc
VRDN
Jun 10, 2024
Signal & Target
BUY
$29.00
Start Price
$6.11
Best Price (1Y)
$27.20
Current Price
$19.56
Return
+220.1%
Akero Therapeutics Inc
AKRO
Jun 10, 2024
Signal & Target
BUY
$40.00
Start Price
$22.99
Best Price (1Y)
$58.40
Current Price
$54.65
Return
+137.7%
Insmed Inc
INSM
May 29, 2024
Signal & Target
BUY
$54.00
Start Price
$48.06
Best Price (1Y)
$84.87
Current Price
$99.21
Return
+106.4%
Alpine Immune Sciences Inc
ALPN
Mar 20, 2024
Signal & Target
BUY
$46.00
Start Price
$40.23
Best Price (1Y)
$65.00
Current Price
$64.97
Return
+61.5%